FDA defers Novo Nordisk's diabetes drug HIV vaccine 'modestly effective' in late-stage clinical trial Clinical trial finds Erbitux as first-line cancer treatment boosts survival rate FDA: Tysabri users may have increased risk of developing deadly brain infection Pfizer reports cancer drug Aromasin aids survival rates in women Valeant to submit epilepsy treatment to FDA for review Abbott receives FDA approval for HIV screening test King Pharmaceuticals announces availability of Embeda Sanofi-Aventis receives complete response letter from the FDA for Ciltyri ADHD drug lands celebrity spokeswoman First Previous 226 227 228 229 230 Next Last
